Stock 688366 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Haohai Biological Technology Co., Ltd. Shanghai S.E.

Equities

688366

CNE100003NX4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
91.7 CNY -0.81% Intraday chart for Shanghai Haohai Biological Technology Co., Ltd. -0.86% -15.32%
Apr. 29 Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 11 Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5% MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,079 13,946 18,971 14,509 15,993 13,913 - -
Enterprise Value (EV) 1 10,882 10,962 16,123 14,509 15,993 13,913 13,913 13,913
P/E ratio 18.5 x 30.3 x 21 x 31.3 x 15 x - 11.3 x -
Yield 1.66% 1.27% 1.67% 1.23% 2.73% - 2.71% -
Capitalization / Revenue 8.78 x 10.5 x 10.7 x 6.9 x 6.07 x 4.34 x 3.69 x 3.1 x
EV / Revenue 8.78 x 10.5 x 10.7 x 6.9 x 6.07 x 4.34 x 3.69 x 3.1 x
EV / EBITDA 26.4 x 37 x 36.2 x 37.8 x 21.9 x 17.4 x 14.7 x 12.1 x
EV / FCF - - 269,465,034 x - - - - -
FCF Yield - - 0% - - - - -
Price to Book 1.37 x 1.07 x 1.31 x - - - - -
Nbr of stocks (in thousands) 177,845 176,622 176,404 171,271 167,091 168,575 - -
Reference price 2 42.09 39.39 41.96 32.55 36.63 39.49 39.49 39.49
Announcement Date 2/27/20 2/25/21 2/27/22 2/27/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,604 1,332 1,767 2,103 2,635 3,203 3,768 4,482
EBITDA 1 533.6 376.6 523.8 384.1 728.7 801.1 947.4 1,153
EBIT 1 435.4 259 383.4 179.9 530.8 636.3 770.9 960.3
Operating Margin 27.14% 19.44% 21.7% 8.55% 20.15% 19.87% 20.46% 21.43%
Earnings before Tax (EBT) 1 434.3 257 382.7 235.7 508.3 637.3 792.2 960.8
Net income 1 370.8 230.1 352.2 180.5 416.1 518.7 643.4 776
Net margin 23.11% 17.27% 19.93% 8.58% 15.79% 16.19% 17.07% 17.32%
EPS 2.270 1.300 2.000 1.040 2.440 - 3.499 -
Free Cash Flow - - 70.4 - - - - -
FCF margin - - 3.98% - - - - -
FCF Conversion (EBITDA) - - 13.44% - - - - -
FCF Conversion (Net income) - - 19.99% - - - - -
Dividend per Share 0.7000 0.5000 0.7000 0.4000 1.000 - 1.071 -
Announcement Date 2/27/20 2/25/21 2/27/22 2/27/23 2/23/24 - - -
1CNY in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 S1
Net sales 1 - 701.6 1,313
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income 1 81.18 124.1 205.2
Net margin - 17.68% 15.63%
EPS 0.4700 - -
Dividend per Share - - -
Announcement Date 4/28/23 8/17/23 8/17/23
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 3,197 2,985 2,848 - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - 70.4 - - - - -
ROE (net income / shareholders' equity) 8.18% 4.2% 6.34% 3.22% 7.45% 8.18% 9.37% 10.3%
ROA (Net income/ Total Assets) - 3.7% 5.31% - - 7.43% 8.66% 9.71%
Assets 1 - 6,225 6,638 - - 6,981 7,429 7,995
Book Value Per Share 30.70 36.90 32.00 - - - - -
Cash Flow per Share 2.140 1.480 1.940 1.330 - - - -
Capex 1 249 195 272 - 265 298 302 332
Capex / Sales 15.53% 14.66% 15.39% - 10.07% 9.3% 8.01% 7.42%
Announcement Date 2/27/20 2/25/21 2/27/22 2/27/23 2/23/24 - - -
1CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shanghai Haohai Biological Technology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
39.49 CNY
Average target price
65.08 CNY
Spread / Average Target
+64.79%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.46% 180B
MEDTRONIC PLC Stock Medtronic plc
+3.39% 112B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.68% 68.53B
DEXCOM, INC. Stock DexCom, Inc.
+5.44% 51.97B
CENCORA, INC. Stock Cencora, Inc.
+5.70% 44.08B
HOYA CORPORATION Stock Hoya Corporation
+5.62% 42.23B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+25.42% 32.43B
TERUMO CORPORATION Stock Terumo Corporation
+16.72% 26.39B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-4.29% 24.97B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6826 Stock
  4. 688366 Stock
  5. Financials Shanghai Haohai Biological Technology Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW